|
2023
|
Invention
|
Quinoline cgas antagonist compounds. The present disclosure provides compounds that are cGAS anta... |
|
|
Invention
|
Quinoline cgas antagonist compounds.
The present disclosure provides compounds that are cGAS ant... |
|
|
Invention
|
Cgas antagonist compounds. Disclosed are novel compounds of Formula I that are cGAS antagonists, ... |
|
2022
|
Invention
|
Sting agonist combination treatments with cytokines.
The disclosure provides, among other things... |
|
|
Invention
|
Sting agonist combination treatments with cytokines. The disclosure provides, among other things,... |
|
|
Invention
|
Cyclic di-nucleotide compounds and methods of use.
Disclosed are cyclic-di-nucleotide cGAMP anal... |
|
2021
|
Invention
|
Antibody-sting agonist conjugates and their use in immunotherapy.
The present disclosure relates... |
|
|
Invention
|
Sting agonist combination treatments with immune checkpoint inhibitors.
The disclosure provides,... |
|
|
Invention
|
Sting agonist combination treatments with immune checkpoint inhibitors. The disclosure provides, ... |
|
|
Invention
|
Antibody-sting agonist conjugates and their use in immunotherapy. The present disclosure relates ... |
|
2020
|
Invention
|
Methods of treating cancer with a sting agonist.
The disclosure provides methods of treating a c... |
|
|
Invention
|
Methods of treating cancer with a sting agonist. The disclosure provides methods of treating a ca... |
|
|
G/S
|
Chemicals and biological preparations for use in the biological, biotechnological, medical, and p... |
|
2019
|
Invention
|
Cyclic di-nucleotide compounds and methods of use. Disclosed are cyclic-di-nucleotide cGAMP analo... |
|
|
G/S
|
Biotechnology research, namely, research and development of pharmaceutical preparations for use i... |
